Glenmark concludes post marketing surveillance (PMS) study on Favipiravir (FabiFlu®)
Sep 15, 2021
Mumbai (Maharashtra) [India], September 15 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced the successful completion of its Post Marketing Surveillance...